SPAC

Healthcare

23andMe Gives Up on its Drug Development Dream

Photo by Mike Mozart via CC BY 2.0

A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.

2 min read

Photo by Scott S via CC BY 2.0

Regulation

The SEC Is Finally Cracking Down on SPACs

Regulators voted in new rules aimed at protecting investors considering investing in the nontraditional setup.

1 min read

Photo by Artem Podrez via Pexels

Advisor Upside

ETFs Are Breaking Inflow Records. Not So Much Overseas

US equity ETFS saw nearly $150 billion in inflows last month. Those tied to Europe, Japan, and emerging markets weren’t so lucky.

1 min read
Photo by Coolcaesar via CC BY-SA 4.0

Healthcare

Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.

2 min read
Photo by Joetimetodo via CC BY-SA 4.0

International Economics

Does a Popular Internet Router Pose a National Security Threat?

If similar cases are a guide, the US has given equal weight to both known and hypothetical threats to national security.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.